Botox drives Allergan sales higher, but earnings slip
Allergan Inc. said Monday its popular anti-wrinkle drug Botox helped drive sales 9.1 percent higher in the first quarter, but net income fell 15.9 percent after restructuring charges, investment losses and accounting changes. Still, the results came in ah
3:33PM ( 23 years ago )